Skip to main content

The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.

Publication ,  Journal Article
Diamond, JM; Cantu, E; Calfee, CS; Anderson, MR; Clausen, ES; Shashaty, MGS; Courtwright, AM; Kalman, L; Oyster, M; Crespo, MM; Bermudez, CA ...
Published in: Am J Respir Crit Care Med
January 1, 2024

Rationale: Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Prior studies implicated proxy-defined donor smoking as a risk factor for PGD and mortality. Objectives: We aimed to more accurately assess the impact of donor smoke exposure on PGD and mortality using quantitative smoke exposure biomarkers. Methods: We performed a multicenter prospective cohort study of lung transplant recipients enrolled in the Lung Transplant Outcomes Group cohort between 2012 and 2018. PGD was defined as grade 3 at 48 or 72 hours after lung reperfusion. Donor smoking was defined using accepted thresholds of urinary biomarkers of nicotine exposure (cotinine) and tobacco-specific nitrosamine (4-[methylnitrosamino]-1-[3-pyridyl]-1-butanol [NNAL]) in addition to clinical history. The donor smoking-PGD association was assessed using logistic regression, and survival analysis was performed using inverse probability of exposure weighting according to smoking category. Measurements and Main Results: Active donor smoking prevalence varied by definition, with 34-43% based on urinary cotinine, 28% by urinary NNAL, and 37% by clinical documentation. The standardized risk of PGD associated with active donor smoking was higher across all definitions, with an absolute risk increase of 11.5% (95% confidence interval [CI], 3.8% to 19.2%) by urinary cotinine, 5.7% (95% CI, -3.4% to 14.9%) by urinary NNAL, and 6.5% (95% CI, -2.8% to 15.8%) defined clinically. Donor smoking was not associated with differential post-lung transplant survival using any definition. Conclusions: Donor smoking associates with a modest increase in PGD risk but not with increased recipient mortality. Use of lungs from smokers is likely safe and may increase lung donor availability. Clinical trial registered with www.clinicaltrials.gov (NCT00552357).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Respir Crit Care Med

DOI

EISSN

1535-4970

Publication Date

January 1, 2024

Volume

209

Issue

1

Start / End Page

91 / 100

Location

United States

Related Subject Headings

  • Tissue Donors
  • Smoking
  • Respiratory System
  • Prospective Studies
  • Primary Graft Dysfunction
  • Lung Transplantation
  • Humans
  • Cotinine
  • Biomarkers
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Diamond, J. M., Cantu, E., Calfee, C. S., Anderson, M. R., Clausen, E. S., Shashaty, M. G. S., … Christie, J. D. (2024). The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation. Am J Respir Crit Care Med, 209(1), 91–100. https://doi.org/10.1164/rccm.202303-0358OC
Diamond, Joshua M., Edward Cantu, Carolyn S. Calfee, Michaela R. Anderson, Emily S. Clausen, Michael G. S. Shashaty, Andrew M. Courtwright, et al. “The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.Am J Respir Crit Care Med 209, no. 1 (January 1, 2024): 91–100. https://doi.org/10.1164/rccm.202303-0358OC.
Diamond JM, Cantu E, Calfee CS, Anderson MR, Clausen ES, Shashaty MGS, et al. The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation. Am J Respir Crit Care Med. 2024 Jan 1;209(1):91–100.
Diamond, Joshua M., et al. “The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.Am J Respir Crit Care Med, vol. 209, no. 1, Jan. 2024, pp. 91–100. Pubmed, doi:10.1164/rccm.202303-0358OC.
Diamond JM, Cantu E, Calfee CS, Anderson MR, Clausen ES, Shashaty MGS, Courtwright AM, Kalman L, Oyster M, Crespo MM, Bermudez CA, Benvenuto L, Palmer SM, Snyder LD, Hartwig MG, Todd JL, Wille K, Hage C, McDyer JF, Merlo CA, Shah PD, Orens JB, Dhillon GS, Weinacker AB, Lama VN, Patel MG, Singer JP, Hsu J, Localio AR, Christie JD. The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation. Am J Respir Crit Care Med. 2024 Jan 1;209(1):91–100.

Published In

Am J Respir Crit Care Med

DOI

EISSN

1535-4970

Publication Date

January 1, 2024

Volume

209

Issue

1

Start / End Page

91 / 100

Location

United States

Related Subject Headings

  • Tissue Donors
  • Smoking
  • Respiratory System
  • Prospective Studies
  • Primary Graft Dysfunction
  • Lung Transplantation
  • Humans
  • Cotinine
  • Biomarkers
  • 3202 Clinical sciences